Breast Cancer
TOS-358-001: A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors
- Details
ClinicalTrials.gov ID:
NCT05683418
Diagnosis Type:
NA
USOR Number:
- Address
,
P: